What is the lead time for production?

The average lead time is one month for both peak and off-season.

What certifications does the product hold?

The product is certified under ISO 9001:2015 quality management system.

ISO Certified Fraxini Extract 98% Aesculin 531-75-9 Natural Ingredient Intermediate

Name: ISO Certified Fraxini Extract 98% Aesculin 531-75-9 Natural Ingredient Intermediate
Brand: Shanghai Tauto Biotech Co., Ltd.
SKU: 1924102632

Shanghai, ChinaShanghai Tauto Biotech Co., Ltd.

US$1,480.00

1 kg

Product profile

Customization

Available

CAS No.

531-75-9

Formula

C15 H16 O9

Model NO.

RM-0243

Type

Ingredients

Appearance

Powder

Quality

Refined

Colour

White

Product

Aesculin

General Source

Fraxini Cortex

Method of Extraction

Solvent Extraction

Assay Method

HPLC

Transport Package

Suitable

Specification

98%

Trademark

Tauto

Origin

China

HS Code

2932209090

Production Capacity

1000 Kg Per Year

Key features

ISO 9001:2015 Certified: Manufactured under strict quality management system standards.

Advanced HSCCC Technology: Utilizes patented chromatography for purification over 98%.

Comprehensive Quality Control: CoA report provided for every shipment with complete QC system.

Customized Production: HSCCC production line can be customized to expand capacity.

Company profile

Shanghai Tauto Biotech Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2010-04-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤15h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryShanghai Tauto Biotech Co., Ltd. is a China-based manufacturing company established in 2006, with 45 employees and a 10,000 m² plant. It develops and produces HSCCC technology, plant extracts, herbal-medicine raw materials, standard materials, and chemical-related products. The supplier holds an ISO 9001:2015 certificate, operates more than 10 production lines, and exports under its own import/export rights to South America, Europe, and North America. Its stated innovation strengths include patented HSCCC technology and an open application laboratory providing research services. Evidence is insufficient to assess after-sales service, customer cases, customization, or financial credibility. Quality-control staffing and R&D experience appear limited based on the stated figures, although the supplier has documented production and research activities.

Supplier typeThe supplier is identified as a factory/manufacturer in Shanghai, China, operating in health, medicine, chemicals, plant extracts, standard materials, and herbal-medicine intermediates. Its stated activities cover research, production, and sales, indicating a vertically involved manufacturing and technology supplier.

CertificationsThe supplier explicitly reports holding an ISO 9001:2015 certificate for its management system. This provides evidence of formal quality-management certification, although no other certifications are stated.

R&D capabilityThe supplier states that it developed a self-patented new-type HSCCC system, operates a global-open HSCCC application laboratory, and conducts research with universities and institutes. These are explicit indicators of technology development and research collaboration, although the stated total R&D-engineer experience is four years.

Production capacityThe supplier is identified as a factory with a 10,000 m² manufacturing plant and more than 10 production lines. It reports production of plant extracts, standard materials, and herbal-medicine-related products, exports to three major regions, and states one-month lead times in both off-peak and peak seasons; however, quality-control staffing is reported as fewer than five people.